DermTech, Inc. DMTK Stock
DermTech, Inc. Price Chart
DermTech, Inc. DMTK Financial and Trading Overview
| DermTech, Inc. stock price | 0.09 USD |
| Previous Close | 3.02 USD |
| Open | 2.97 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 800 |
| Day's Range | 2.87 - 3.06 USD |
| 52 Week Range | 1.55 - 8.93 USD |
| Volume | 288.53K USD |
| Avg. Volume | 397.53K USD |
| Market Cap | 90.16M USD |
| Beta (5Y Monthly) | 2.547281 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.1 USD |
DMTK Valuation Measures
| Enterprise Value | 44.7M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.99656355 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.315102 |
| Price/Book (mrq) | 0.84057975 |
| Enterprise Value/Revenue | 3.131 |
| Enterprise Value/EBITDA | -0.378 |
Trading Information
DermTech, Inc. Stock Price History
| Beta (5Y Monthly) | 2.547281 |
| 52-Week Change | -39.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.93 USD |
| 52 Week Low | 1.55 USD |
| 50-Day Moving Average | 3.07 USD |
| 200-Day Moving Average | 3.53 USD |
DMTK Share Statistics
| Avg. Volume (3 month) | 397.53K USD |
| Avg. Daily Volume (10-Days) | 498.73K USD |
| Shares Outstanding | 31.09M |
| Float | 27.12M |
| Short Ratio | 5.7 |
| % Held by Insiders | 4.14% |
| % Held by Institutions | 27.56% |
| Shares Short | 2.82M |
| Short % of Float | 9.41% |
| Short % of Shares Outstanding | 9.09% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -840.64% |
| Gross Margin | 0.97% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.0080% |
| Return on Equity (ttm) | -75.85% |
Income Statement
| Revenue (ttm) | 14.28M USD |
| Revenue Per Share (ttm) | 0.47 USD |
| Quarterly Revenue Growth (yoy) | -6.50% |
| Gross Profit (ttm) | 647K USD |
| EBITDA | -118291000 USD |
| Net Income Avi to Common (ttm) | -117845000 USD |
| Diluted EPS (ttm) | -3.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 104.78M USD |
| Total Cash Per Share (mrq) | 3.37 USD |
| Total Debt (mrq) | 55.58M USD |
| Total Debt/Equity (mrq) | 51.83 USD |
| Current Ratio (mrq) | 6.964 |
| Book Value Per Share (mrq) | 3.45 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -92465000 USD |
| Levered Free Cash Flow (ttm) | -50252000 USD |
Profile of DermTech, Inc.
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 12340 El Camino Real |
| ZIP | 92130 |
| Phone | 858 450 4222 |
| Website | https://www.dermtech.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 278 |
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.
Q&A For DermTech, Inc. Stock
What is a current DMTK stock price?
DermTech, Inc. DMTK stock price today per share is 0.09 USD.
How to purchase DermTech, Inc. stock?
You can buy DMTK shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DermTech, Inc.?
The stock symbol or ticker of DermTech, Inc. is DMTK.
Which industry does the DermTech, Inc. company belong to?
The DermTech, Inc. industry is Diagnostics & Research.
How many shares does DermTech, Inc. have in circulation?
The max supply of DermTech, Inc. shares is 34.96M.
What is DermTech, Inc. Price to Earnings Ratio (PE Ratio)?
DermTech, Inc. PE Ratio is 0.00000000 now.
What was DermTech, Inc. earnings per share over the trailing 12 months (TTM)?
DermTech, Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the DermTech, Inc. company belong to?
The DermTech, Inc. sector is Healthcare.
DermTech, Inc. DMTK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17461.32 USD — |
+0.55
|
12.35B USD — | 17256.2 USD — | 17500.41 USD — | — - | 12.35B USD — |
| NASDAQ Capital Market Composite RCMP | 102.12 USD — |
+0.01
|
— — | 100.88 USD — | 102.45 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 933.61 USD — |
+0.28
|
— — | 922.07 USD — | 938.83 USD — | — - | — — |
- {{ link.label }} {{link}}